Revenue Recognition Policy Review and Benchmarking for Pre-IPO Companies

The Hong Kong Stock Exchange’s (HKEX) 2024 consultation on Listing Rule amendments, which proposed enhanced disclosure requirements for revenue recognition policies of companies with significant non-cash or barter transactions, signals a definitive shift in regulatory scrutiny ahead of the anticipated 2025-2026 listing cycle. For pre-IPO companies targeting a Main Board or GEM listing, a revenue recognition policy that merely complies with HKFRS 15 is no longer sufficient; the Exchange is increasingly focused on the substance over form of revenue streams, particularly for businesses in technology, platform, and project-based sectors. The SFC’s 2023 thematic inspection of sponsor work, which cited revenue recognition as a top deficiency area in IPO prospectuses, reinforces this pressure. A policy that is not benchmarked against industry peers and explicitly aligned with HKEX’s interpretive guidance on contract liabilities, variable consideration, and principal-versus-agent assessments will invite multiple rounds of Listing Department queries, delaying the A1 filing and potentially jeopardising valuation. This article provides a structured framework for CFOs, company secretaries, and legal counsel to systematically review and strengthen revenue recognition policies before engaging a sponsor, using specific HKFRS 15 requirements and HKEX Listing Rules as the analytical backbone.

The Regulatory Pressure Points: Why a Standard HKFRS 15 Policy Fails the IPO Test

The primary risk for a pre-IPO company is not technical non-compliance with HKFRS 15, but a policy that is too generic to withstand the detailed scrutiny of the HKEX Listing Division’s vetting process. The Exchange’s 2024 consultation paper on Listing Rule amendments explicitly targets situations where revenue is recognised based on milestones that are not clearly defined or where the company’s policy on variable consideration (e.g., rebates, volume discounts, performance bonuses) is opaque. The SFC’s 2023 report on sponsor inspections noted that in 40% of reviewed cases, the sponsor’s due diligence on revenue cut-off and contract modifications was inadequate, leading to material misstatements in draft prospectuses.

HKEX Listing Rule 11.07 and the “Sufficiency of Operations” Requirement.
The HKEX’s “sufficiency of operations” test under Listing Rule 11.07 for Main Board applicants and GEM Rule 11.12A requires the issuer to demonstrate a track record of revenue generation from its core business. A revenue recognition policy that retroactively reclassifies or accelerates revenue from long-term contracts—for example, by recognising the full contract value at signing rather than over time—will immediately trigger a “substance over form” query. The Exchange will request a detailed breakdown of contract assets and contract liabilities, cross-referenced against the company’s billing milestones and payment terms. For a pre-IPO company, the policy must be drafted to show that revenue is recognised in a manner that reflects the actual transfer of control to the customer, not merely the contractual right to invoice.

HKFRS 15’s Five-Step Model and the Principal-vs-Agent Trap.
The most contentious area in pre-IPO audits remains the principal-versus-agent assessment under HKFRS 15, Step 4. The SFC has publicly stated that sponsors must obtain independent evidence to support the company’s conclusion that it controls the specified good or service before transfer to the customer. For platform-based businesses (e.g., e-commerce marketplaces, online travel agencies, gig-economy platforms), the default presumption is that they are agents unless they can demonstrate inventory risk, pricing discretion, or primary responsibility for fulfilment. A policy that merely states “we are a principal” without robust evidence of control will be rejected. The benchmark for pre-IPO companies should be the HKFRS 15 illustrative examples B34–B40, which detail the indicators of control. Any deviation from these examples must be explicitly justified in the accounting policies note.

Variable Consideration and the Constraint on Estimates.
HKFRS 15 requires companies to estimate variable consideration using either the expected value or the most likely amount method, but it also imposes a constraint: revenue can only be recognised to the extent that it is highly probable that a significant reversal will not occur. Pre-IPO companies in sectors with high return rates (e.g., consumer electronics, fashion retail) or significant performance bonuses (e.g., software-as-a-service, infrastructure contracting) must disclose not only the method used but also the specific quantitative thresholds applied. The HKEX’s 2024 guidance on Listing Document Contents (Appendix 1A, Part I, Paragraph 27) explicitly requires disclosure of the key assumptions and sensitivities around revenue recognition estimates. A policy that omits this granularity will be flagged as insufficient.

Benchmarking Your Policy Against Industry Peers and HKEX Interpretations

A pre-IPO revenue recognition policy must be benchmarked against at least three peer companies that have successfully listed on the Main Board or GEM within the last 24 months. The goal is to identify the specific disclosure patterns that the Listing Division has accepted, particularly around contract modifications, performance obligations, and the timing of revenue recognition.

The “Milestone” Trap in Project-Based Businesses.
For engineering, construction, and IT implementation companies, the most common pitfall is the definition of “milestones.” The HKEX has repeatedly queried issuers where milestones are defined in terms of internal project phases (e.g., “design complete,” “testing phase”) rather than customer-verifiable events (e.g., “customer sign-off on design specification,” “successful completion of user acceptance testing”). The benchmark for pre-IPO companies should be the prospectus of a comparable listed entity in the same sector. For example, a Hong Kong-listed construction firm’s revenue recognition policy typically states that revenue is recognised “over time using the input method based on labour hours incurred as a proportion of total estimated labour hours,” with customer-verified milestones serving as a validation check. A pre-IPO company with a policy that relies solely on internal project management reports without third-party customer confirmation will face a significant deficiency.

Licensing and Royalty Revenue: The “Right to Use” vs. “Right to Access” Distinction.
Technology and intellectual property (IP)-driven companies face a specific challenge under HKFRS 15: distinguishing between a “right to use” a functional IP (revenue recognised at a point in time) and a “right to access” a symbolic IP (revenue recognised over time). The HKEX’s 2022 guidance on listing applications for biotech and tech companies under Chapter 18C (Specialist Technology Companies) emphasised that the nature of the licence must be clearly disclosed. For a pre-IPO company with a licensing model, the policy must include a detailed analysis of whether the IP’s utility changes over time (symbolic) or remains static (functional). The benchmark should be the prospectuses of recently listed biotech firms under Chapter 18A, which typically disclose that revenue from out-licensing arrangements is recognised at the point in time when control of the licence is transferred, unless the company has an ongoing obligation to maintain or update the IP.

Multiple-Element Arrangements: The Allocation of Transaction Price.
Pre-IPO companies that bundle hardware, software, and services into a single contract must allocate the transaction price to each distinct performance obligation based on standalone selling prices. The HKEX’s Listing Division has a history of querying issuers that use residual methods (i.e., allocating the residual amount to services after allocating to hardware) without adequate justification. The SFC’s 2023 report on sponsor work specifically cited inadequate documentation of standalone selling price estimation as a recurring deficiency. The benchmark for pre-IPO companies is to use observable prices for identical or similar goods or services sold separately, with a clear disclosure of the estimation methodology (e.g., adjusted market assessment approach, expected cost plus margin approach). Any use of the residual method must be explicitly justified by reference to HKFRS 15’s guidance on highly variable or uncertain standalone selling prices.

Contract Assets, Contract Liabilities, and the Cash Flow Trap

The transition from a private company’s revenue recognition policy to a public company’s disclosure regime is most visible in the treatment of contract assets and contract liabilities (formerly known as unbilled receivables and deferred revenue). The HKEX’s 2024 consultation on Listing Rule amendments explicitly targets the quality of disclosure around these balance sheet items, particularly for companies with significant upfront payments or milestone-based billing.

Contract Assets vs. Trade Receivables: The Impairment Risk.
A pre-IPO company must clearly distinguish between a contract asset (a right to consideration that is conditional on something other than the passage of time, e.g., completion of a future milestone) and a trade receivable (an unconditional right to consideration). The HKFRS 9 expected credit loss (ECL) model applies to both, but the risk profile differs materially. For a contract asset, the ECL must incorporate the risk that the customer may not accept the future milestone, which is a higher risk than a standard trade receivable. The HKEX’s Listing Division will request a detailed breakdown of contract assets by ageing and by project status, along with the company’s methodology for estimating ECLs on these assets. A policy that lumps all contract assets into a single line item with a standard 1% ECL rate will be rejected as insufficient.

Contract Liabilities and the “Refund Liability” Trap.
Companies that receive upfront payments from customers must carefully distinguish between a contract liability (an obligation to transfer goods or services) and a refund liability (an obligation to refund consideration if the customer exercises a right of return). The HKEX’s 2024 guidance on Listing Document Contents requires disclosure of the expected timing of satisfaction of contract liabilities, broken down into within one year and beyond one year. For a pre-IPO company with significant contract liabilities, the policy must include a reconciliation of the opening and closing balances, showing the amount of revenue recognised that was included in the contract liability balance at the beginning of the period. This is a standard disclosure under HKFRS 15.15, but many pre-IPO companies fail to prepare this reconciliation before the A1 filing, causing delays.

The Cash Flow Statement Impact.
The Listing Division will also scrutinise the relationship between revenue recognised and cash collected. For a company that recognises revenue on a percentage-of-completion basis but collects cash only at final handover, the cash flow from operations will be negative even as revenue grows. The HKEX’s Listing Rules require a discussion of the company’s working capital position, and a revenue recognition policy that masks a deteriorating cash conversion cycle will be a red flag. The benchmark for pre-IPO companies is to prepare a pro-forma cash flow statement that reconciles revenue recognition to cash collections for the three most recent financial years, and to include this analysis in the “Business” section of the prospectus, not just the financial notes.

The Sponsor’s Due Diligence Checklist and the Pre-A1 Filing Review

The SFC’s Code of Conduct for Sponsors (Paragraph 17) requires the sponsor to conduct reasonable due diligence to ensure that the revenue recognition policy is appropriate and that the underlying transactions are genuine. For a pre-IPO company, the internal review of the revenue recognition policy must mirror the sponsor’s due diligence checklist to identify gaps before the A1 filing.

The “Top-Down” vs. “Bottom-Up” Approach to Revenue Testing.
The SFC expects sponsors to use a “top-down” analytical review to identify unusual revenue patterns (e.g., a spike in Q4 revenue, a sudden change in the mix of product vs. service revenue) and then conduct “bottom-up” testing on a sample of contracts. The pre-IPO company should proactively prepare a revenue variance analysis for the last three financial years, explaining any quarter-over-quarter or year-over-year changes in revenue recognition patterns. The policy must be able to withstand a query such as: “Why did revenue from customer X increase 300% in the final year while the number of contracts signed remained flat?” The answer must be found in the policy’s application, not in a post-hoc rationalisation.

The “Contract Modification” Query.
The HKEX’s Listing Division frequently queries issuers on how they account for contract modifications, particularly in long-term projects where scope changes are common. Under HKFRS 15, a modification can be accounted for as a separate contract (if the additional goods or services are distinct and the price reflects their standalone selling prices) or as a modification of the existing contract (prospectively or through a cumulative catch-up adjustment). A pre-IPO company must have a documented policy for classifying modifications, including the specific thresholds used to determine whether the price reflects standalone selling prices. The benchmark is to have at least three examples of actual contract modifications from the track record period, with the accounting treatment clearly documented and audited.

The “Right of Return” and “Warranty” Distinction.
For companies in the consumer goods or technology hardware sectors, the distinction between a right of return (accounted for as a refund liability and an asset for the right to recover returned goods) and a warranty (accounted for as a provision under HKAS 37 or as a separate performance obligation under HKFRS 15 if it is a service-type warranty) is a common source of error. The HKEX’s 2024 guidance on Listing Document Contents requires disclosure of the nature and extent of return rights and warranty obligations. A policy that treats all returns as a reduction of revenue without recognising a separate refund liability will be non-compliant. The pre-IPO company must have a documented returns history for the last three years and a statistically valid methodology for estimating expected returns.

Actionable Takeaways for the Pre-IPO Finance Team

1. Prepare a revenue recognition policy memo that explicitly maps each revenue stream to the five steps of HKFRS 15, cross-referenced to the specific HKFRS 15 paragraphs and HKEX Listing Rule appendix references, before engaging a sponsor. This memo becomes the primary document for the sponsor’s due diligence and the Listing Division’s review.

2. Conduct a principal-versus-agent assessment for each material revenue stream, using the HKFRS 15 illustrative examples B34–B40 as the benchmark, and document the evidence for each indicator of control (inventory risk, pricing discretion, primary responsibility for fulfilment). The SFC will request this documentation during the sponsor’s inspection.

3. Prepare a reconciliation of contract assets and contract liabilities for the three most recent financial years, including the ageing of contract assets by project and the expected timing of satisfaction of contract liabilities. This reconciliation is a mandatory disclosure under HKFRS 15.15 and will be a primary focus of the Listing Division’s queries.

4. Benchmark the policy’s disclosure on variable consideration, including the method used (expected value or most likely amount) and the quantitative constraint applied, against the prospectuses of three comparable listed peers in the same sector. The HKEX’s 2024 consultation explicitly requires this level of granularity.

5. Simulate the sponsor’s “top-down” analytical review by preparing a revenue variance analysis for the last three financial years, identifying any quarter-over-quarter or year-over-year anomalies, and documenting the business rationale for each anomaly in the policy memo. This pre-emptive preparation will reduce the number of queries during the A1 filing review.